ProPhase Labs, Inc. reported that it regained compliance with Nasdaq listing rules after appointing Carolina Abenante to fill a vacancy on its Audit Committee, with the appointment effective July 19, 2025. This notice is in response to an earlier compliance issue reported on September 26, 2024.